stockportfolio.pro
Stocks / ALGN vs AXSM
ALGN vs AXSM
Align Technology, Inc. and Axsome Therapeutics, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Align Technology, Inc. (ALGN) | Axsome Therapeutics, Inc. (AXSM) | |
|---|---|---|
| Market cap | $12.8B | $13.0B |
| Revenue (latest FY) | $4.03B | $638.50M |
| Net income (latest FY) | $410.35M | $-183.17M |
| Revenue growth (5y CAGR) | 10.3% | — |
| Net margin | 10.2% | -28.7% |
| Return on equity | 10.1% | -207.5% |
| P/E ratio | 29.9 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 0 |
| Positive free cash flow | Yes | No |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open ALGN — free Open AXSM — freeFrequently asked questions
Which is bigger, ALGN or AXSM?
Axsome Therapeutics, Inc. is larger by market capitalization — $13.0B versus $12.8B.
Which grows faster, ALGN or AXSM?
Five-year growth data is not available for both companies.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.